Literature DB >> 31576631

Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome.

Sarah M O'Donovan1,2,3, Erin K Crowley3,4, Jillian R-M Brown1, Orla O'Sullivan1,5, Olivia F O'Leary1,3,4, Suzanne Timmons1,3,6, Yvonne M Nolan1,3,4, David J Clarke1,7, Niall P Hyland1,8, Susan A Joyce1,2, Aideen M Sullivan1,3,4, Cora O'Neill1,2,3.   

Abstract

BACKGROUND: A hallmark feature of Parkinson's disease (PD) is the build-up of α-synuclein protein aggregates throughout the brain; however α-synuclein is also expressed in enteric neurons. Gastrointestinal (GI) symptoms and pathology are frequently reported in PD, including constipation, increased intestinal permeability, glial pathology, and alterations to gut microbiota composition. α-synuclein can propagate through neuronal systems but the site of origin of α-synuclein pathology, whether it be the gut or the brain, is still unknown. Physical exercise is associated with alleviating symptoms of PD and with altering the composition of the gut microbiota.
METHODS: This study investigated the effects of bilateral nigral injection of adeno-associated virus (AAV)-α-synuclein on enteric neurons, glia and neurochemistry, the gut microbiome, and bile acid metabolism in rats, some of whom were exposed to voluntary exercise. KEY
RESULTS: Nigral overexpression of α-synuclein resulted in significant neuronal loss in the ileal submucosal plexus with no change in enteric glia. In contrast, the myenteric plexus showed a significant increase in glial expression, while neuronal numbers were maintained. Concomitant alterations were observed in the gut microbiome and related bile acid metabolism. Voluntary running protected against neuronal loss, increased enteric glial expression, and modified gut microbiome composition in the brain-injected AAV-α-synuclein PD model. CONCLUSIONS AND INFERENCES: These results show that developing nigral α-synuclein pathology in this PD model exerts significant alterations on the enteric nervous system (ENS) and gut microbiome that are receptive to modification by exercise. This highlights brain to gut communication as an important mechanism in PD pathology.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  Parkinson's disease; enteric nervous system; exercise; gut-brain axis; microbiome

Mesh:

Substances:

Year:  2019        PMID: 31576631     DOI: 10.1111/nmo.13726

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  20 in total

Review 1.  Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate α-synuclein cytotoxicity in disease-modifying therapy for Parkinson's disease.

Authors:  Makoto Naoi; Wakako Maruyama; Masayo Shamoto-Nagai
Journal:  J Neural Transm (Vienna)       Date:  2020-01-28       Impact factor: 3.575

Review 2.  The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic.

Authors:  Ai Huey Tan; Shen Yang Lim; Anthony E Lang
Journal:  Nat Rev Neurol       Date:  2022-06-24       Impact factor: 44.711

3.  Distinct Bile Acid Signature in Parkinson's Disease With Mild Cognitive Impairment.

Authors:  Kun Nie; Yanyi Li; Jiahui Zhang; Yuyuan Gao; Yihui Qiu; Rong Gan; Yuhu Zhang; Lijuan Wang
Journal:  Front Neurol       Date:  2022-07-04       Impact factor: 4.086

Review 4.  Gastrointestinal dysfunction in the synucleinopathies.

Authors:  Kathryn A Chung; Ronald F Pfeiffer
Journal:  Clin Auton Res       Date:  2020-11-27       Impact factor: 4.435

Review 5.  Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.

Authors:  Vinod Metta; Valentina Leta; Kandadai Rukmini Mrudula; L K Prashanth; Vinay Goyal; Rupam Borgohain; Guy Chung-Faye; K Ray Chaudhuri
Journal:  J Neurol       Date:  2021-04-21       Impact factor: 4.849

Review 6.  Neurodegenerative disorders and gut-brain interactions.

Authors:  Alpana Singh; Ted M Dawson; Subhash Kulkarni
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 19.456

Review 7.  Modulation of the Microbiome in Parkinson's Disease: Diet, Drug, Stool Transplant, and Beyond.

Authors:  Ethan G Brown; Samuel M Goldman
Journal:  Neurotherapeutics       Date:  2020-10-09       Impact factor: 6.088

Review 8.  Gut brain axis: an insight into microbiota role in Parkinson's disease.

Authors:  Sara Ayman Moustafa; Shrouk Mohamed; Abdelhameed Dawood; Jihan Azar; Ekramy Elmorsy; Noura A M Rizk; Mohamed Salama
Journal:  Metab Brain Dis       Date:  2021-08-09       Impact factor: 3.584

Review 9.  Modeling Parkinson's Disease With the Alpha-Synuclein Protein.

Authors:  Mónica Gómez-Benito; Noelia Granado; Patricia García-Sanz; Anne Michel; Mireille Dumoulin; Rosario Moratalla
Journal:  Front Pharmacol       Date:  2020-04-23       Impact factor: 5.810

Review 10.  Immune-microbiome interplay and its implications in neurodegenerative disorders.

Authors:  Ankit Uniyal; Vineeta Tiwari; Mousmi Rani; Vinod Tiwari
Journal:  Metab Brain Dis       Date:  2021-08-06       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.